KUSH PARMAR - Director, 10%+ Owner at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

KUSH PARMAR - trading volume in the past year for Entrada Therapeutics, Inc.

Holdings reported by KUSH PARMAR for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,963,066 $26,074,980 $8.80 14 Nov 2025 By 5AM Ventures V, L.P.
Common Stock 1,093,313 $6,756,674 $6.18 14 Nov 2025 By 5AM Opportunities I, L.P.
Stock Option (Right to Buy) 19,000 11 Jun 2025 Direct Common Stock

Transactions reported by KUSH PARMAR for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.